 |
Poster communications
At Which Point and for Which Reasons Are Oral MTX Formulations Switched to Injectable Ones in RA Patients? Combined Results from 3 Independent Observational and Clinical Trials
Rm Flipo
1
A. Saraux
2, 3
Christophe Hudry
4, 5
C Gaujoux-Viala
6
E Senbel
7
S Tropé
8
E Zinovieva
9
A Courbeyrette
9
H Herman-Demars
9
H Herman-Demars 9
Author
1
Hôpital Roger Salengro [Lille] (Clinique Neurologique - Neurologie A - 2 av. Oscar Lambert 59037 Lille cedex - France)
2
LBAI - Lymphocyte B et Auto-immunité (5 Foch - CHU Morvan - BP 824 - 29609 Brest - France - France)
- UBO - Université de Brest (Université de Bretagne Occidentale - 3 Rue des Archives 29238, Brest - France)
- IBSAM - Institut Brestois Santé Agro Matière (Université de Brest- UBO
29238 Brest - France)
- UBO - Université de Brest (Université de Bretagne Occidentale - 3 Rue des Archives 29238, Brest - France)
- INSERM - Institut National de la Santé et de la Recherche Médicale : U1227 (101, rue de Tolbiac, 75013 Paris - France)
3
CHU - BREST - Rhumato - CHRU Brest - Service de Rhumatologie (Hôpital de la Cavale Blanche, Boulevard Tanguy Prigent, 29200 Brest - France)
4
Hôpital Cochin [AP-HP] (27 Rue du Faubourg Saint-Jacques 75014 Paris - France)
5
Service de rhumatologie [CHU Cochin] (27 rue du Faubourg Saint-Jacques 75014 Paris - France)
- Hôpital Cochin [AP-HP] (27 Rue du Faubourg Saint-Jacques 75014 Paris - France)
- AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP) (France)
6
AIDMP - Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (641 Avenue du doyen Gaston Giraud
34093 Montpellier France - France)
- UM1 - Université Montpellier 1 : EA2415 (5, boulevard Henri IV - CS 19044 - 34967 Montpellier cedex - France)
- UM - Université de Montpellier : EA 2415 (163 rue Auguste Broussonnet - 34090 Montpellier - France)
7
Rheumatology Office, Marseille France (France)
8
Andar, Paris (France)
9
Medical Department Nordic Pharma, Paris (Paris - France)
Document type :
Poster communications
Domain :
Complete list of metadata
https://hal.univ-brest.fr/hal-01950293
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Monday, December 10, 2018 - 4:35:30 PM
Last modification on : Tuesday, March 15, 2022 - 9:39:36 AM
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Monday, December 10, 2018 - 4:35:30 PM
Last modification on : Tuesday, March 15, 2022 - 9:39:36 AM
Identifiers
- HAL Id : hal-01950293, version 1
Collections
UNIV-BREST | MIPS | UNIV-MONTPELLIER | IMMUNO | IBSAM
Citation
Rm Flipo, A. Saraux, Christophe Hudry, C Gaujoux-Viala, E Senbel, et al.. At Which Point and for Which Reasons Are Oral MTX Formulations Switched to Injectable Ones in RA Patients? Combined Results from 3 Independent Observational and Clinical Trials. ACR/ARHP Annual Meeting, Oct 2018, Chicago, United States. 70 (suppl 10) (Abstract 601), Arthritis Rheumatology. ⟨hal-01950293⟩
Metrics
Record views